AdamChristopherElNaggarMDMD(He/Him)

PubMed

• Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall surviv...
  Ying L Liu, Cara A Mathews, Fiona Simpkins, Karen A Cadoo, Diane Provencher
  Cancer. 2025-01-15
• Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.
  Arnab Basu, Cherry Au, Ajitha Kommalapati, Hyndavi Kandala, Sumedha Sudhaman
  JCO Precision Oncology. 2024-12-01
• 3 citations
  Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.
  Andres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, Ryan M Winters, Mustafa Balcioglu
  The Oncologist. 2024-10-03

Journal Articles

• A Comparison of Outcomes following Robotic-Assisted Staging and Laparotomy in patients with Early Stage Endometrioid Adenocarcinoma of the Uterus with Uterine Weight U...  
  Ulm, M.A., Ginn, D.N., ElNaggar, A.C., Tillmanns, T.D., Reed, K.M., Wan, J.Y., Watson, C.H., Dedania, S.J., Reed, M.E., Gynecology and Minimally Invasive Therapy, 1/1/2016
• "Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting Associated With Robotic Gynecologic Surgery: A Randomized, Double-Blinded, P...  
  Lee, D., Tillmanns, T.D., Ulm, M., Mabe, A., Kumar, S., ElNaggar, A.C., Journal of Gynecologic Surgery, 1/1/2015

Abstracts/Posters

• Close vulvar cancer margins are not strongly associated with recurrence or survival.
  C. Cosgrove, A. ElNaggar, M. Ulm, R. Sarin, E. Hade, P. Blackburn, T. Tillmanns, M. Reed, D. Cohn, J. Fowler., Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort.
  A. ElNaggar, R. Neff, M. Ulm, L. Lambrecht, U. Naeem, S. Pollock, J. Fowler, D. Cohn, F. Backes, T. Tillmanns, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter?
  C. Watson, A. ElNaggar, T. Tillmanns, M. Ulm, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series.
  C. Coffman, A. ElNaggar, A. Talbot, C. Carr, S. Baum, T. Tillmanns, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a national cancer institute-designated comprehensive cancer center.
  A. ElNaggar, M. Liang, E. Hade, L. Copeland, J. Fowler, R. Salani, F. Backes, D. O'Malley, D. Cohn, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control?
  L. Daily, M. Ulm, A. ElNaggar, T. Tillmanns, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• A Multi-Institutional Analysis of Surgery and Chemotherapy for Stage IVB Carcinosarcoma of the Uterus.
  Vandersluis, A., Wade, K.S., Ding, K., Backes, F., Cosgrove, C., ElNaggar, A.C., Richardson, D., Roane, B, Erickson, B., Leath, C.A., Moore, K.N., Gunderson, C.C., SGO Winter Meeting, Breckenridge, CO, 1/1/2017
• Elevated STAT3 expression in ovarian tumor ascites regulates invasion and metastasis: a promising therapeutic target.
  Saini, U., Naidu, S., ElNaggar, A., Heman, B., Wallbillich, J., Wanner, R., Bixel, K., Riley, M. Bolyard, C., Suarez, A. Kaur, B., Kuppusamy, P., Hays, J., Goodfellow,..., Late-Breaking Research: Tumor Biology 1; Section 11, American Association for Cancer Research Annual Meeting, New Orleans, LA, 1/1/2016
• Targeting constitutively-activated STAT3 in hypoxic ovarian cancer.
  McCann, G., ElNaggar, A., Naidu, S., Rath, K., Tierney, B., Suarez, A., Cohn, D., Selvendiran, K., Clin Cancer Res, Marsha Rivkin Center for Ovarian Cancer Research and the American Association for Cancer Research 10th Biennial Ovarian Cancer Research Symposium, Seattle, WA, 2014, 1/1/2015
• The effects of obesity on robotic-assisted pelvic and periaortic node sampling in endometrial cancer.
  Reed, K., Ulm, M., ElNaggar, A., Tillmanns, T., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• A comparison of progression free survival and postoperative outcomes for early stage endometrioid adenocarcinoma following robotic-assisted staging and laparotomy.
  Ulm, M., Ginn, D., ElNaggar, A., Tillmanns, T., Reed, K., Watson, C., Dedania, S., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model.
  Naidu, S., Saini, U., ElNaggar, A., Rath, K., Heman, B., Lata, P., Wanner, R., Sudhakar, E., Hideg, K., Suarez, A., Hays, J., Houghton, P., Goodfellow, P., Cohn, D., S..., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and HO-4318, in ovarian cancer.
  ElNaggar, A., Naidu, S., Saini, U., Wanner, R., Sudhakar, E., Cohn, D., Selvendiran, K., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Utility of intraoperative frozen section of the inguinofemoral sentinel lymph node in vulvar cancer: a retrospective cohort.
  ElNaggar, A., Coffman, C., Davis, E., Duncan, M., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC).
  Liang, M., ElNaggar, A., Nekkanti, S., O'Malley, D., Hade, E., Copeland, L., Fowler, J., Salani, R., Backes, F., Cohn, D., Gynecologic Oncology, Featured Poster. Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• HO-3867, a selective inhibitor of stat3, suppress ovarian tumor growth and metastasis in human tissue culture and in an orthotopic mouse model.
  Naidu, S., Saini, U., ElNaggar, A., Heman, B., Wanner, R., Bixel, K., Suarez, A., Bolyard, C., Kaur, B., Goodfellow, P., Kuppusamy, P., Cohn, D., Selvendiran, K., Cancer Research, American Association for Cancer Research Annual Meeting, Philadelphia, PA, 1/1/2015
• Suppression of ovarian tumor growth and metastasis with a STAT3 inhibitor, HO-3867, in preclinical orthotopic models and ex vivo cultures of ovarian cancer.
  Naidu, S., Saini, U., ElNaggar, A., Rath, KS, Hemant, BK, Lata, P., Wanner, R., Sudhakar, E., Hideg, K., Hays, J., Houghton, P., Goodfellow, PJ, Cohn, DE, Selvendiran, K., Cancer Research, The Ohio State University 16th Annual Scientific Meeting, American Association for Cancer Research Annual Meeting, Columbus, OH, 2014; San Diego, CA, 2014, 1/1/2014
• High Resolution Anoscopy for the Detection of Anal Intraepithelial Neoplasia.
  ElNaggar, A.C., Likes, W., Gynecologic Oncology, Focused Plenary: Surgical Film Session, Society of Gynecologic Oncology 45th Annual Meeting, Tampa Bay, FL, 1/1/2014
• Risk Factors for Anal Intraepithelial Neoplasia.
  ElNaggar, A., Kumar, S., Santoso, J., Gynecologic Oncology, Western Association Gynecologic Oncologist & Felix Rutledge Society Annual Meeting, Huntington Beach, CA, 1/1/2012
• Guided Outcomes in Learned Efficiency (GOLE) Model of Medical Education: A Prospective Randomized Controlled Trial.
  Patil A., ElNaggar, A.C., Tillmanns, T., CREOG/APGO, Orlando, FL, 1/1/2012
• Outcomes of ovarian cancer patients after bevacizumab and chemotherapy in primary vs. recurrent setting – A multi-institutional study.
  Chan, J., Secord, A., Tillmanns, T., Moore, K., Bevis, K., ElNaggar, A., Perry, L., McClung, C., Tian, C., Huh, W., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• The efficacy and safety of chemotherapy in combination with bevacizumab vs. bevacizumab alone in recurrent epithelial ovarian cancer-A multi-institutional study .
  Fuh, K., Secord, A., Huh, W., Tillmanns, T., Moore, K., Bevis, K., ElNaggar, A., Previs, R., Kiet, T., Chan, J., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• Trends of bevacizumab use and toxicity in advanced ovarian cancer over the last 7 years: A multi-institutional study.
  Chapman, J., Fuh, K., Alvarez-Secord, A., Huh, W., Tillmanns, T., Moore, K., Bevis, K., Polin, M., ElNaggar, A., Chan, J., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• Team Climate Inventory as a Tool to Assess Provider Dynamics in an Academic Outpatient Clinic.
  Patil, A., ElNaggar, A.C., Shephard, C., Duke Medicine 6th Annual Patient Safety & Quality Conference, Durham, NC, 1/1/2010
• Neo-adjuvant chemotherapy followed by TAH BSO lymph node dissection vs. TAH BSO lymph node dissection followed by chemotherapy for Stage III-IV epithelial endometrial ...
  Lambrecht, L., ElNaggar, A.C., Kumar, S., Tillmanns, T., Western Association of Gynecologic Oncologists, Santa Barbara, CA, 1/1/2010
• Join now to see all

Lectures

• A randomized controlled trial comparing the efficacy of perioperative celecoxib versus ketorolac for perioperative pain control. 
  National Harbor, MD - 1/1/2017
• "Ovarian Cancer: Update on Screening" 
  Memphis, TN - 1/1/2017
• "Prevention of Lower Genital Tract Malignancies" 
  Grant Medical Center, Columbus, OH - 1/1/2016
• "Current management of gestational trophoblastic disease" 
  Columbus, OH - 1/1/2016
• Gynecologic malignancies. 
  The Ohio State University-Wexner Medical Center, Columbus, OH - 1/1/2015
• "CREOG Review: Lower Genital Tract disease and GTD" 
  The Ohio State University-Wexner Medical Center, Columbus, OH - 1/1/2015
• Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and HO-4318, in ovarian cancer. 
  Chapel Hill, NC - 1/1/2014
• "Cervical Cancer Screening: How did we get here?" 
  Memphis, TN - 1/1/2014
• "CREOG Review: Gynecologic Oncology" 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2014
• Comparison of robotic assisted and laparotomy recurrence rates in the staging and treatment of early stage endometrial cancer: a retrospective study. 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2013
• Keratosis reduces sensitivity of anal cytology in detecting anal intraepithelial neoplasia. 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2012
• Birth Weight Discordance and Lung Maturity in Triplet Births. 
  Maui, HI - 1/1/2009
• Phosphofructokinase Gene Regulation in Post-Implantation Mice Embryos. 
  University of Chicago, 2003; Anderson University, 2004; Anderson, IN, 2004 - 1/1/2004
• Join now to see all

Other

• Raising the bar on screening. 
  Salani, R, ElNaggar, A, View on the News, Ob.Gyn.News
  1/1/2015
• High resolution anoscopy for the detection of anal intraepithelial neoplasia. 
  ElNaggar, A., Likes, W., Robbins, D., & Thorpe, E., Obstetrics & Gynecology (Surgical Film)
  1/1/2014